IP Library Patent Application 16336016
Patent Application
App. No. 16/336,016

APOAEQUORIN AND VITAMIN D-CONTAINING COMPOSITIONS AND METHODS OF USING SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/336,016
Abstract

Compositions containing apoaequorin and vitamin D and methods for their use in treating symptoms and disorders related to calcium imbalances and vitamin D deficiency associated with, for example, sleep quality, energy quality, mood quality, memory quality or pain are provided by the present invention

Claims (21)

1 . A composition for treating a symptom or disorder associated with at least one of calcium imbalance and vitamin D deficiency, comprising: (a) an effective amount of apoaequorin; (b) an effective amount of vitamin D; and (c) an acceptable carrier.

2 . The composition according to claim 1 , wherein the composition is in the form of a unit dosage containing said effective amounts of the apoaequorin and vitamin D.

3 . The composition according to claim 2 , wherein: (a) the effective amount of apoaequorin in the unit dosage is about 10 mg to about 50 mg; and (b) the effective amount of vitamin D in the unit dosage is about 25 mcg to about 75 mcg.

4 . The composition according to claim 3 , wherein: (a) the effective amount of apoaequorin in the unit dosage is about 20 mg; and (b) the effective amount of vitamin D in the unit dosage is about 50 mcg.

5 . The composition according to claim 1 , wherein the vitamin D is in the form of D3 cholecalciferol.

6 . The composition according to claim 1 , wherein the unit dosage is a capsule.

7 . The composition according to claim 1 , wherein the composition is a nutraceutical composition.

8 . A method for treating a symptom or disorder associated with at least one of calcium imbalance and vitamin D deficiency, comprising administering to a subject in need of such treatment an effective amount of a composition according to claim 1 .

9 . The method according to claim 8 , wherein the symptom or disorder is sleep-related and administration of the composition to said subject improves sleep quality in the subject.

10 . The method according to claim 8 , wherein the symptom or disorder is energy-related and administration of the composition to said subject improves energy quality in the subject.

11 . The method according to claim 8 , wherein the symptom or disorder is mood-related and administration of the composition to said subject improves mood quality in the subject.

12 . The method according to claim 8 , wherein the symptom or disorder is pain-related and administration of the composition to said subject alleviates pain in the subject.

13 . The method according to claim 8 , wherein the symptom or disorder is memory-related and administration of the composition to said subject improves memory quality in the subject.

14 . The method according to claim 8 , wherein the symptom or disorder is related to neuronal excitability, muscle contraction, membrane permeability, cell division, hormone secretion, bone mineralization, or cell death following ischemia.

15 .- 18 . (canceled)

19 . The method according to claim 8 , wherein the composition is in the form of a unit dosage containing said effective amounts of the apoaequorin and vitamin D.

20 . The method according to claim 19 , wherein: (a) the effective amount of apoaequorin in the unit dosage is about 10 mg to about 50 mg; and (b) the effective amount of vitamin D in the unit dosage is about 25 mcg to about 75 mcg.

21 . The method according to claim 19 , wherein: (a) the effective amount of apoaequorin in the unit dosage is about 20 mg; and (b) the effective amount of vitamin D in the unit dosage is about 50 mcg.

22 . The method according to claim 8 , wherein the vitamin D is in the form of D3 cholecalciferol.

23 . The method according to claim 19 , wherein the unit dosage is a capsule.

24 . The method according to claim 8 , wherein the composition is a nutraceutical composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2021
From: UNDERWOOD, MARK Y
To: QUINCY BIOSCIENCE, LLC
Reel/Frame 054929/0786 →